The company increased its 2024 full-year revenue, gross margin and operating expense guidance as follows: revenue of $132M to $137M , representing implied growth of 48% to 54% compared to 2023, up from prior guidance of $128 to $135M.. Gross margin in the range of 68% to 70%, representing an implied increase of 800 basis points to 1,000 basis points compared to 2023, up from prior guidance of 65% to 67%.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXST:
- RxSight, Inc. Reports First Quarter 2024 Financial Results
- Rxsight, Inc. (RXST) Q1 Earnings Cheat Sheet
- RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024
- RxSight launches its newest light adjustable lens, the LAL+
- RxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting